Cronos Group Inc (CRON) support and resistance · P/E 14, rev $117.6M
Cronos Group Inc (CRON) is a drug manufacturers - specialty & generic company listed on US.
This page maps Cronos Group Inc (CRON) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported CRON revenue for 2024-12-31 was $117.6M. Net income was $40.0M. Revenue was up 34.8% from 2023-12-31 to 2024-12-31. CRON currently screens at market cap $738.3M and trailing P/E 13.6.
CRON currently screens at market cap $738.3M and trailing P/E 13.6. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new CRON 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the CRON quote page for the session range and the stock page for the full model.
Not investment advice.